The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review

SA SeyedAlinaghi, P Mirzapour, Z Pashaei… - AIDS Research and …, 2023 - Springer
Introduction The COVID-19 epidemic and various control and mitigation measures to combat
the widespread outbreak of the disease may affect other parts of health care systems. There …

Long-term interplay between COVID-19 and chronic kidney disease

H Schiffl, SM Lang - International Urology and Nephrology, 2023 - Springer
Purpose The COVID-19 pandemic may have an impact on the long-term kidney function of
survivors. The clinical relevance is not clear. Methods This review summarises the currently …

Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19

P Laurent, C Yang, AF Rendeiro… - Science …, 2022 - science.org
Lung-infiltrating macrophages create a marked inflammatory milieu in a subset of patients
with COVID-19 by producing a cytokine storm, which correlates with increased lethality …

COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review

SA SeyedAlinaghi, A Karimi, A Barzegary… - European Journal of …, 2022 - Springer
Introduction Patients with immunodeficiency are usually more prone to worse outcomes of
infectious diseases. However, there are some disagreements in the context of COVID-19, for …

B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity

D Lapuente, TH Winkler, M Tenbusch - Cellular & Molecular …, 2024 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
prompted scientific, medical, and biotech communities to investigate infection-and vaccine …

TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population

A Yaghoobi, JS Lord, JS Rezaiezadeh… - PLoS …, 2023 - journals.plos.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been responsible for
the recent pandemic since early 2020. Due to the wide range of clinical symptoms of this …

[HTML][HTML] Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial

F Wang, W Xiao, Y Tang, M Cao, D Shu… - The Lancet Regional …, 2023 - thelancet.com
Summary Background SIM0417 (SSD8432) is an orally administered coronavirus main
proteinase (3CL pro) inhibitor with potential anti-SARS-CoV-2 activity. This study aimed to …

Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection

J Hou, Y Wei, J Zou, R Jaffery, L Sun, S Liang… - Nature …, 2024 - nature.com
Host anti-viral factors are essential for controlling SARS-CoV-2 infection but remain largely
unknown due to the biases of previous large-scale studies toward pro-viral host factors. To …

Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection

T Zhou, NJ Gilliam, S Li, S Spandau, RM Osborn… - Mbio, 2023 - Am Soc Microbiol
Defective viral genomes (DVGs) have been identified in many RNA viruses as a major factor
influencing antiviral immune response and viral pathogenesis. However, the generation and …

The impact of COVID-19 pandemic on the levels of physical activity: a systematic review

E Mehraeen, A Karimi, P Mirghaderi… - … Current Drug Targets …, 2023 - ingentaconnect.com
Introduction: Earlier studies demonstrated a decreased level of physical activity (PA) during
the COVID-19 pandemic. Therefore, we aimed to systematically review the relevant studies …